Onglyza and Kombiglyze XR Heart Failure Lawsuits

Thousands of people who took the diabetes drug Onglyza or its extended-release version, Kombiglyze XR, may be eligible to file a lawsuit against the drug makers. These lawsuits allege that Onglyza and Kombiglyze XR increase the risk of heart failure and other complications, but the drugmakers failed to warn consumers of the risk. In some cases, these drugs have been linked to serious complications, including pancreatitis and heart failure.

The drugmakers sold Onglyza in 2009 without conducting any studies to determine its risk. After a study published in the New England Journal of Medicine showed that patients who took the drug were more likely to suffer heart failure, the FDA issued a Drug Safety Communication about the drug. The panel of experts recommended that the label be changed to warn patients of the risk. But when AstraZeneca Pharmaceuticals LP submitted its pre-market study to the FDA, the drug maker received serious concerns about the study.

The panel recommended that the drugmaker provide information about the risks of Onglyza and Kombiglyze to doctors and consumers. The FDA has also issued guidance to the drug makers on how to update the labels of these medications.

The drugmakers ignored the warnings Eligible for a Kombiglyze XR lawsuit that were required by the FDA. Instead, they placed their profit-making goals above consumer safety, according to lawsuits filed by plaintiffs. Several people have filed lawsuits against AstraZeneca. Others have filed against BMS, the manufacturer of Kombiglyze XR.

The lawsuits allege that the drugmakers failed to warn consumers about the risks of heart failure and other complications, such as pancreatitis. They also claim that the manufacturers failed to warn consumers of the risk of death. In addition, the lawsuits also allege that the drugmakers failed to warn about the risks of pancreatic cancer.

In a number of cases, plaintiffs are suing because they allege that Onglyza and Kombiglyze caused them to suffer from heart failure, which can lead to death. The plaintiffs claim that the manufacturers failed to warn them of the risks and that the manufacturers were negligent in the way that they developed and marketed the drugs.

Some of the lawsuits are against AstraZeneca and BMS, but there are also lawsuits against individual manufacturers. For instance, John Wesley Hunt Sr. was hospitalized twice after taking Onglyza for only one month. He suffered from congestive heart failure and myocardial infarctions. He also filed a lawsuit against Bristol-Myers Squibb.

The lawsuits are based on allegations of strict liability. AstraZeneca denied claims that the drug increased the risk of pancreatic cancer, but it has been cited in FDA complaints. The FDA panel also ordered the manufacturers of Onglyza to provide information about the risks of heart failure.

If you or a loved one has been diagnosed with heart failure, contact an attorney right away to learn more about your rights. It may be possible to receive compensation for medical expenses, lost wages, and pain and suffering. It is also possible to file a class action lawsuit on behalf of other people who suffered similar injuries.